HomeNewsTrendsEntertainmentOnly 12 of 332 COVID-19 claims in ads in FY21 were true, says ad regulator ASCI

Only 12 of 332 COVID-19 claims in ads in FY21 were true, says ad regulator ASCI

'Brands that offer proven benefits to consumers have a genuine role in the pandemic, but unfortunately most of the COVID-19 related advertising fell woefully short. Most advertisers were unable to prove that the products actually worked to help consumers in a real way as claimed in the ads,' according to ASCI Secretary General Manisha Kapoor

July 26, 2021 / 13:34 IST
Story continues below Advertisement
Representative image
Representative image

Barely 12 of the 332 advertisements for a range of products claiming to provide benefits related to COVID-19 made valid claims, as brands exploited consumer vulnerabilities to peddle their goods during the pandemic, the Advertising Standards Council of India (ASCI) said.

The self-regulatory, voluntary organization of the advertising industry in India assessed advertisements of paints, apparel, detergents, skin care, ACs, fans, water purifiers, plywood and laminates, supplements and food- all promising COVID-19-related benefits.

Story continues below Advertisement

It picked 332 COVID-19 related ads through consumer complaints as well as its own monitoring and found that brands were taking .

ASCI’s expert panel that comprises microbiologists examined COVID-19 related evidence provided by advertisers.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show